Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors-Reference-Cited by-同舟云学术

Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors

Published:2023-05 Issue: Volume:357 Page:67-83
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Anthiya Shubaash,Öztürk Süleyman Can,Yanik Hamdullah,Tavukcuoglu Ece,Şahin Adem,Datta Dhrubajyoti,Charisse Klaus,Álvarez David Moreira,Loza María Isabel,Calvo Alfonso,Sulheim Einar,Loevenich Simon,Klinkenberg Geir,Schmid Ruth,Manoharan Muthiah,Esendağlı Güneş,Alonso Maria Jose

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference76 articles.

1. Development of siRNA payloads to target KRAS -mutant cancer;Yuan;Cancer Discov.,2014

2. Targeting the untargetable KRAS in cancer therapy;Liu;Acta Pharm. Sin. B,2019

3. KRAS-mutant non-small cell lung cancer: from biology to therapy;Ferrer;Lung Cancer,2018

4. Mutant KRAS is a druggable target for pancreatic cancer;Zorde Khvalevsky;Proc. Natl. Acad. Sci.,2013

5. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy;Fleming;Mol. Cancer Res.,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the impact of lipid nanoparticles on protein stability and cellular proteostasis;Journal of Colloid and Interface Science;2025-01

2. Exploring dose and downregulation dynamics in lipid nanoparticles based siRNA therapy: Systematic review and meta-analysis;International Journal of Biological Macromolecules;2024-10

3. Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors;Journal of Controlled Release;2024-09

4. Development and applications of lipid hydrophilic headgroups for nucleic acid therapy;Biotechnology Advances;2024-09

5. Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals;Journal of Drug Targeting;2024-08-07